317 related articles for article (PubMed ID: 23909005)
21. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
McIlhenny EH; Riba J; Barbanoj MJ; Strassman R; Barker SA
Biomed Chromatogr; 2011 Sep; 25(9):970-84. PubMed ID: 21058415
[TBL] [Abstract][Full Text] [Related]
22. William Burroughs: Sailor of the Soul.
Lees AJ
J Psychoactive Drugs; 2017; 49(5):385-392. PubMed ID: 28796595
[TBL] [Abstract][Full Text] [Related]
23. Ayahuasca Alters Structural Parameters of the Rat Aorta.
Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
[TBL] [Abstract][Full Text] [Related]
24. Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users.
Ona G; Kohek M; Massaguer T; Gomariz A; Jiménez DF; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
J Psychoactive Drugs; 2019; 51(2):135-145. PubMed ID: 30732540
[TBL] [Abstract][Full Text] [Related]
25. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED
Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017
[TBL] [Abstract][Full Text] [Related]
26. The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study.
Maia LO; Daldegan-Bueno D; Tófoli LF
J Psychoactive Drugs; 2021; 53(3):272-282. PubMed ID: 33287690
[TBL] [Abstract][Full Text] [Related]
27. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil.
Barbosa PC; Giglio JS; Dalgalarrondo P
J Psychoactive Drugs; 2005 Jun; 37(2):193-201. PubMed ID: 16149333
[TBL] [Abstract][Full Text] [Related]
28. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
29. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
[TBL] [Abstract][Full Text] [Related]
30. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.
Rocha JM; Rossi GN; de Lima Osório F; Bouso JC; de Oliveira Silveira G; Yonamine M; Campos AC; Bertozi G; Cecílio Hallak JE; Dos Santos RG
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):267-274. PubMed ID: 33843820
[TBL] [Abstract][Full Text] [Related]
31. Adverse Effects After Ayahuasca Administration in the Clinical Setting.
Rocha JM; Rossi GN; Osório FL; Hallak JEC; Dos Santos RG
J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):321-324. PubMed ID: 35289542
[No Abstract] [Full Text] [Related]
32. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry.
McIlhenny EH; Pipkin KE; Standish LJ; Wechkin HA; Strassman R; Barker SA
J Chromatogr A; 2009 Dec; 1216(51):8960-8. PubMed ID: 19926090
[TBL] [Abstract][Full Text] [Related]
33. Assessment of addiction severity among ritual users of ayahuasca.
Fábregas JM; González D; Fondevila S; Cutchet M; Fernández X; Barbosa PC; Alcázar-Córcoles MÁ; Barbanoj MJ; Riba J; Bouso JC
Drug Alcohol Depend; 2010 Oct; 111(3):257-61. PubMed ID: 20554400
[TBL] [Abstract][Full Text] [Related]
34. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
35. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
[TBL] [Abstract][Full Text] [Related]
36. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
Riba J; Rodríguez-Fornells A; Barbanoj MJ
Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
[TBL] [Abstract][Full Text] [Related]
37. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
38. The expansion of the field of research on ayahuasca: some reflections about the ayahuasca track at the 2010 MAPS "Psychedelic Science in the 21st Century" conference.
Labate BC; Cavnar C
Int J Drug Policy; 2011 Mar; 22(2):174-8. PubMed ID: 21051213
[No Abstract] [Full Text] [Related]
39. Subjective time under altered states of consciousness in ayahuasca users in shamanistic rituals involving music.
Campagnoli APS; Pereira LAS; Bueno JLO
Braz J Med Biol Res; 2020; 53(8):e9278. PubMed ID: 32578718
[TBL] [Abstract][Full Text] [Related]
40. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
Favaro VM; Yonamine M; Soares JC; Oliveira MG
PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
